Ocugen, Inc. — Director's Dealing 2019

Dec 16, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-27

Reporting Person: Leo Frank (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	103122	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$2.94	2025-08-26	Common Stock (14382)		Direct
Warrants (Right to Buy)	$5.05	2026-12-08	Common Stock (1266)		Direct
Warrants (Right to Buy)	$7.56	2027-05-23	Common Stock (3307)		Direct

Footnotes

F1: 100% of the Stock Options became exercisable immediately.

F2: 100% of the Warrants became exercisable immediately.